Investor Info

Opsens is focused on becoming a key player in the Fractional Flow Reserve (FFR) pressure guidewire market with its innovative OptoWire using proprietary fiber optic pressure sensor and OptoMonitor system. Introducing the first Nitinol-based fiber optic pressure sensing guidewire, the OptoWire is designed to provide cardiologists with optimized performance for navigating in the coronary arteries and to reach blockages with ease while also measuring intra-coronary blood pressure. In addition to innovative guidewire construction, the pressure guidewire is instrumented with Opsens’ well-proven high fidelity optical pressure sensing technology that delivers reliable FFR diagnostic, also allowing easy and reliable connectivity further improving FFR measurement and post PCI assessment reliability.

Opsens – Analyst Coverage

Opsens is currently covered by

Firm: Ladenburg Thalmann
Analyst: Jeffrey S. Cohen

Firm: M Partners
Analyst: Steven Salz

Firm: Paradigm Capital
Analyst: Christopher Lam

Firm: RBC
Analyst: Doug Miehm

The above list is provided for information purposes only. Opinions, estimates and/or forecasts regarding Opsens’ performance made by this or these analysts is their(s) alone and does not necessarily reflect opinions, forecasts or predictions of Opsens’ and/or its management.


Louis Laflamme
President and CEO
750, Boul. du Parc Technologique,
Québec, QC
Canada G1P 4S3

Tel.: 418.781.0333
Fax.: 418.781.0024
[email protected]


Deloitte, s.e.n.c.r.l.
925, Grande-Allée Ouest
Suite 400
Quebec, QC

Tel.: +1 418 624 3333
Fax.: +1 418 624 0414

Transfer Agent & Registrar

Canadian Stock Transfer Company Inc. (CST)
320 Bay Street
B1 Level
Toronto, ON M5H4A6
Tel.: 1-800-387-0825

* Links to third party sites are for informational purposes only. Opsens Inc. have not prepared, reviewed or updated any content on third party sites and assume no responsibility for the information posted on them.

() %

Financial email alert

First name *

Last name *

Your Email *